Actively Recruiting
Epithelioid Haemangioendothelioma Observational Study
Led by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · Updated on 2026-04-01
50
Participants Needed
1
Research Sites
405 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The EHE observational study was developed to obtain a high number of datas such as clinical presentation, natural history, and treatment outcomes, cto identificate cytokines and hormones as biomarkers and generate patient-derived preclinical models as a tool to assess the activity of anticancer agents and validate novel therapeutic targets
CONDITIONS
Official Title
Epithelioid Haemangioendothelioma Observational Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histological diagnosis of epithelioid hemangioendothelioma (EHE) based on 2020 WHO classification from biopsy or surgery
- Signed informed consent
- Adequate ability to comply with treatment or follow-up
- No age limit for participation
You will not qualify if you...
- Inability to ensure adequate compliance with study requirements
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fondazione IRCCS IstitutoNazionale dei Tumori
Milan, Italy, 20133
Actively Recruiting
Research Team
S
Silvia Stacchiotti
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
5
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here